Chinese biotech startup Lepu Biotech has raised an aggregate of 1.291 billion yuan ($186 million) in a Series B round co-led by Ping An Insurance (Group)’s investment vehicle Ping An Capital and Sunshine Insurance Group-backed private equity firm Riverhead Capital Investment Management.
Other new investors include state-owned SDIC Unity Capital, Haitong Securities’ Haitong Innovation Capital Management, and Qingdao Minxin Qiyuan Investment, and China Reform Holdings Corporation’s joint fund, Lepu announced on WeChat.
